Leading Separation Sciences Company, Phenomenex, Releases New Beneficial Core-Shell Column

Torrance, Calif. (June 17th, 2019) – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, introduces the Kinetex 2.6 µm PS C18 – the eleventh selectivity in the Kinetex core-shell HPLC/UHPLC family. The new core-shell PS C18 phase is beneficial for all types of compounds (acids, bases, neutrals), but... Read more

New Immobilized Lux Chiral LC/SFC Selector from Phenomenex Delivers Broad Enantioselectivity and Robustness

TORRANCE, Calif., March 19, 2019 /PRNewswire/ — Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, expands its Lux chiral LC/SFC column family with a third new immobilized chiral media—Lux i-Amylose-3. During the manufacturing of Lux immobilized media, a chemical crosslinking is formed between the polysaccharide and silica support, resulting... Read more

Phenomenex Opens Office for Direct Sales and Support in Taiwan

Torrance, Calif. (January 7, 2019) – Phenomenex, Inc., a global leader in the research and manufacturer of advanced technologies for the separation sciences, announced today that it has opened an office to directly serve customers in Taiwan. Phenomenex is a leading player in proprietary chromatography consumables, serving the liquid and gas chromatography market. Over the... Read more

New Luna Omega HILIC Column Delivers Increased LC Separation of Sugars

Torrance, Calif. (July 19, 2018) – Phenomenex Inc., global leader in the research, design and manufacture of advanced technologies for the separation sciences, announces a new Luna Omega phase for sugar analysis by hydrophilic interaction chromatography (HILIC). Luna Omega SUGAR is specifically engineered for carbohydrate separation and analysis from food, beverage and pharmaceutical matrices, such as milk, animal... Read more

Phenomenex Opens Office for Sales and Support in Singapore

Torrance, Calif. (June 7, 2018) – Phenomenex, Inc., a global leader in the research and manufacturer of advanced technologies for the separation sciences, announced today that it has opened an office to directly serve customers in Singapore. Phenomenex has been doing business in Singapore through distributors since 1993. Direct presence allows Phenomenex to provide customers... Read more

Phenomenex Announces Direct Sales and Support in Singapore

Torrance, Calif. (May 1, 2018) – Phenomenex, Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announced today that it will begin to directly serve customers in Singapore, effective May 1, 2018. Direct presence in Singapore will allow Phenomenex to provide customers with a variety of services such... Read more

New GC Column with Unsurpassed Inertness Delivers Advanced Performance for Volatiles Analysis

Torrance, Calif. (May 10, 2018) – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, introduces Zebron™ ZB-624PLUS™ GC columns for volatile organic compound analysis. Incorporating a higher level of inertness than previous offerings, the columns are stable up to 300/320 ˚C and their superior deactivation process enhances peak... Read more

Phenomenex Introduces bioZen Series for Characterization of Biotherapeutics

Torrance, Calif. (April 16, 2018) – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, introduces bioZen – a new series of LC solutions for bioseparations in pharmaceutical, biopharmaceutical and academic research. The series encompasses both proven and entirely new media spanning two particle platforms – core-shell... Read more

New SPE Solution Streamlines Urine Drug Testing Workflow

Torrance, Calif. (April 10, 2018) – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, introduces Strata®-X-Drug B Plus – a solid phase extraction (SPE) sample preparation product for urine drug testing in clinical and forensic toxicology labs. An expansion of Phenomenex’s drug testing product line, the new Drug B Plus... Read more